<!--https://www.openaustralia.org.au/debates/?id=2009-11-25.36.1-->
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
 <head>
  <meta content="text/html; charset=utf-8" http-equiv="Content-Type"/>
  <title>
   Second Reading: 25 Nov 2009: House debates (OpenAustralia.org)
  </title>
  <meta content="Making parliament easy." name="description"/>
  <meta content="Parliament, government, House of Representatives, Senate, Senator, MP, Member of Parliament, MPs, Australia, Australian, Second Reading: 25 Nov 2009" name="keywords"/>
  <meta content="5FBaCDi8kCKdo4s64NEdB5EOJDNc310SwcLLYHmEbgg=" name="verify-v1"/>
  <meta content="width=device-width; initial-scale=1.0; maximum-scale=1.0" name="viewport">
   <link href="mailto:contact@openaustralia.org" rel="author" title="Send feedback"/>
   <link href="http://www.openaustralia.org.au/" rel="home" title="Home"/>
   <link href="/" rel="start" title="Home"/>
   <!-- skin: mobile -->
   <link href="/style/default/global_non_ns4_mobile.css" rel="stylesheet" type="text/css"/>
   <link href="/style/default/mobile.css" rel="stylesheet" type="text/css"/>
   <link href="/style/default/print.css" media="print" rel="stylesheet" type="text/css"/>
   <script type="text/javascript">
    var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www.");
document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E"));
   </script>
   <script type="text/javascript">
    var pageTracker = _gat._getTracker("UA-3107958-3");
pageTracker._initData();
pageTracker._trackPageview();
   </script>
  </meta>
 </head>
 <body>
  <div id="container">
   <a name="top">
   </a>
   <div id="banner">
    <div id="title">
     <h1>
      <a href="/" title="To the front page of the site">
       <img alt="OpenAustralia.org beta" height="32" src="/images/openaustraliaorgbeta.gif" width="262"/>
      </a>
     </h1>
    </div>
   </div>
   <!-- end #banner -->
   <div id="content">
    <div class="stripe-head-1">
     <div class="main">
      <h2>
       House debates
      </h2>
      <h3>
       Wednesday, 25 November 2009
      </h3>
      <h4>
       Therapeutic Goods (Charges) Amendment Bill 2009
      </h4>
      <h5>
       Second Reading
      </h5>
      <p>
       11:00 am
      </p>
      <a name="g36.2">
      </a>
      <p class="speaker">
       <a href="/mp/?m=73" title="See more information about Mark Butler">
        <img alt="Photo of Mark Butler" class="portrait" src="/images/mps/10086.jpg"/>
        <strong>
         Mark Butler
        </strong>
       </a>
       <small>
        (Port Adelaide, Australian Labor Party, Parliamentary Secretary for Health) |
        <a href="http://parlinfo.aph.gov.au/parlInfo/search/display/display.w3p;query=Id:chamber/hansardr/2009-11-25/0000" title="The source of this piece of text">
         Hansard source
        </a>
        <!-- | <script type="text/javascript" src="http://parlvid.mysociety.org/video.cgi?gid=2009-11-25.36.2&output=js-link"></script> -->
       </small>
       <p>
        I move:
       </p>
       <p class="moved">
        That this bill be now read a second time.
       </p>
       <p>
        This
        <a href="http://parlinfo.aph.gov.au/parlInfo/search/display/display.w3p;query=Id:legislation/billhome/R4254" rel="nofollow">
         bill
        </a>
        makes consequential amendments to the Therapeutic Goods (Charges) Act 1989 as a result of the Therapeutic Goods Amendment (2009 Measures No. 3) Bill 2009 which I have just discussed.
       </p>
       <p>
        This bill allows annual charges to be imposed for the continued inclusion of biologicals in the register. This is consistent with the inclusion of other therapeutic goods in the register.
       </p>
       <p>
        It also provides that where a medicine or biological is temporarily suspended from the register under the Therapeutic Goods Act 1989 it can continue to be taken to be included in the register for the purpose of the Charges Act. This is because the medicine or biological is only temporarily suspended for part of the year and during the suspension the usual regulatory work necessary in relation to the good continues.
       </p>
       <p>
        A similar provision is already in the Charges Act for medical devices. This amendment just makes consistent the treatment of all therapeutic goods that are suspended.
       </p>
       <p>
        Debate (on motion by
        <b>
         Dr Stone
        </b>
        ) adjourned.
       </p>
       <br/>
       <br/>
       <br/>
       <br/>
       <div id="footer">
        <p>
         <a href="/?show_pc">
          View the PC OA website
         </a>
        </p>
       </div>
      </p>
     </div>
    </div>
   </div>
  </div>
 </body>
</html>
